Report from the Task Force on Zoonoses Data Collection including guidance for harmonized monitoring and reporting of antimicrobial resistance in commensal Escherichia coli and Enterococcus spp. from food animals

EFSA Journal

Volumn 6, Issue 4, 2008, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85078366726     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2008.141r     Document Type: Article

References (71)

1. Devriese, L.A., Pot, B. and Collins M.D. (1993) Phenotypic Identification of the Genus Enterococcus and Differentiation of Phylogenetically Distinct Enterococcal Species and Species Groups. Journal of Applied Bacteriology 75, 399–408.
2. Dutka-Malen S., Evers S., Courvalin P. (1995) Detection of Glycopeptide Resistance Genotypes and Identification to the Species Level of Clinically Relevant Enterococci by PCR. Journal of Clinical Microbiology 33, 24–27. Erratum in Journal of Clinical Microbiology (1995) 33, 1434.
3. ISO 20776–1:2006. International Organisation for Standardization. Clinical laboratory testing and in vitro diagnostic test systems – Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices – Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. ISO, Geneva, Switzerland.
4. Johnson, A.P., Warner, M., Hallas, G. and Livermore D.M. 2000. Susceptibility to Quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid 1999. Journal Antimicrobial Chemotherapy 46, 125–128.
5. Kahlmeter, G., D. F. Brown, F. W. Goldstein, A. P. MacGowan, J. W. Mouton, A. Osterlund, A. Rodloff, M. Steinbakk, P. Urbaskova, and A. Vatopoulos, 2003. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. Journal Antimicrobial Chemotherapy 52, 145–148.
6. Livermore D.M., Brown D.F. Detection of beta-lactamase-mediated resistance. Journal Antimicrobial Chemotherapy 2001;48 Suppl. 1:59–64.
7. Livermore, D.M., Winstanley, T.G., Shannon, K.P., 2001, Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 48 Suppl 1, 87–102.
8. Murray P.R. et al. Manual of Clinical Microbiology. ASM Press 2003. Chapter 18.
9. Neidhardt F. C., 1996. Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington D. C.
10. Frank M. Aarestrup, Patrick F. McDermott, Gunnar Kahlmeter. Antimicrobial susceptibility testing Clinical break points and epidemiological cut-off values. Newsletter CRL-AR – No 2, November 2007. www.crl-ar.eu/_pdf/newsletters/11%2007%20Newsletter%20No%20%202.pdf
11. Wang H.H., Manuzon M., Lehman M., Wan K., Luo H., Wittu T., Yousef A., Bakaletz L.O. Food commensal microbes as a potentially important avenue in transmitting antibiotic resistance genes. FEMS Microbiological Letters 254 (2006) 226–231.
12. WHO report 2007. Critically important antimicrobials for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use: report of the second WHO Expert Meeting, Copenhagen, 29–31 May 2007. ISBN 978 92 4 159574 2.
13. Winokur P. L., Vonstein D. L., Hoffman L. J., Uhlenhopp E. K., and Doern G. V., 2001. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrobial Agents Chemotherapy, 45, 2716–2722.
14. Aarestrup, F.M., Ahrens, P., Madsen, M., Pallesen, L.V., Poulsen, R.L., Westh, H., 1996, Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother 40, 1938–1940.
15. Anonymous 2007a. Critically important antimicrobials for human medicine: Categorisation for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use (Copenhagen, World Health Organization).
16. Anonymous, 2007b, Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement (M100-S17). Clinical and Laboratory Standards Institute (CLSI), Wayne, Pennsylvania.
17. Arias, C.A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castaneda, E., Villegas, M.V., Murray, B.E., Quinn, J.P., 2008, Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase. J Clin Microbiol.
18. Bager, F., Madsen, M., Christensen, J., Aarestrup, F.M., 1997, Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med 31, 95–112.
19. Bauernfeind, A., Casellas, J.M., Goldberg, M., Holley, M., Jungwirth, R., Mangold, P., Rohnisch, T., Schweighart, S., Wilhelm, R., 1992, A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20, 158–163.
20. Bean, D.C., Livermore, D.M., Papa, I., Hall, L.M., 2005, Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother 56, 962–964.
21. Boyd, D., Peters, G.A., Cloeckaert, A., Boumedine, K.S., Chaslus-Dancla, E., Imberechts, H., Mulvey, M.R., 2001, Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol 183, 5725–5732.
22. Bozdogan, B., Leclercq, R., 1999, Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob Agents Chemother 43, 2720–2725.
23. Bradford, P.A., 2001, Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14, 933–951, table of contents.
24. Brinas, L., Lantero, M., de Diego, I., Alvarez, M., Zarazaga, M., Torres, C., 2005, Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 56, 1107–1110.
25. Bush, K., Jacoby, G.A., Medeiros, A.A., 1995, A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39, 1211–1233.
26. Carattoli, A., Lovari, S., Franco, A., Cordaro, G., Di Matteo, P., Battisti, A., 2005, Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 49, 833–835.
27. Carias, L.L., Rudin, S.D., Donskey, C.J., Rice, L.B., 1998, Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 180, 4426–4434.
28. Chow, J.W., 2000, Aminoglycoside resistance in enterococci. Clin Infect Dis 31, 586–589.
29. Coque, T.M., Singh, K.V., Weinstock, G.M., Murray, B.E., 1999, Characterization of dihydrofolate reductase genes from trimethoprim-susceptible and trimethoprim-resistant strains of Enterococcus faecalis. Antimicrob Agents Chemother 43, 141–147.
30. Costa, Y., Galimand, M., Leclercq, R., Duval, J., Courvalin, P., 1993, Characterization of the chromosomal aac(6′)-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 37, 1896–1903.
31. Courvalin, P., 2005, Genetics of glycopeptide resistance in gram-positive pathogens. Int J Med Microbiol 294, 479–486.
32. Crider, S.R., Colby, S.D., 1985, Susceptibility of enterococci to trimethoprim and trimethoprimsulfamethoxazole. Antimicrob Agents Chemother 27, 71–75.
33. DANMAP 2005. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. ISSN 1600-2032.
34. Davies, J., Wright, G.D., 1997, Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 5, 234–240.
35. Duarte, A., N. Faria, T. Conceição, M. Correia, L. M. Lito, J. M. Cristino, M. J. Salgado, and R. Tenreiro. 2002. Identification of TEM-10 ß-lactamase in a Kluyvera sp. and other Enterobacteriaceae at a Portuguese hospital. Antimicrob. Agents Chemother. 46, 4041–4042
36. FARM 2003–2004. French antimicrobial resistance monotoring in bacteria of animal origin, Sanders, P., Corinne, D., eds. ISBN 2-11-095838.
37. Fines, M., Leclercq, R., 2000, Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors. J Antimicrob Chemother 45, 797–802.
38. Guardabassi, L., Courvalin, P., 2006, Modes of antimicrobial action and mechanisms of bacterial resistance, In: Aarestrup, F.M. (Ed.) Antimicrobial resistance in bacteria of animal origin. ASM Press, Washington, pp. 1–18.
39. Hakenbeck, R., Coyette, J., 1998, Resistant penicillin-binding proteins. Cell Mol Life Sci 54, 332–340.
40. Hasman, H., Mevius, D., Veldman, K., Olesen, I., Aarestrup, F.M., 2005, beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother 56, 115–121.
41. Health Protection Agency (2006). Laboratory detection and reporting of bacteria with extended spectrum β-lactamases. National Standard Method QSOP 51 Issue 2. www.hpastandardmethods.org.uk/pdf_sops.asp.
42. Hope, R., Potz, N.A., Warner, M., Fagan, E.J., Arnold, E., Livermore, D.M., 2007, Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae. J Antimicrob Chemother 59, 110–113.
43. Hopkins, K.L., Davies, R.H., Threlfall, E.J., 2005, Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25, 358–373.
44. Hornish, R.E., Kotarski, S.F., 2002, Cephalosporins in veterinary medicine - ceftiofur use in food animals. Curr Top Med Chem 2, 717–731.
45. Huovinen, P., Sundstrom, L., Swedberg, G., Skold, O., 1995, Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 39, 279–289.
46. Jacoby, G.A., 2005, Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl 2, S120–126.
47. Klare, I., Heier, H., Claus, H., Reissbrodt, R., Witte, W., 1995, vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 125, 165–171.
48. Klare, I., Konstabel, C., Badstubner, D., Werner, G., Witte, W., 2003, Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 88, 269–290.
49. Klare, I., Rodloff, A.C., Wagner, J., Witte, W., Hakenbeck, R., 1992, Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 36, 783–787.
50. Leclercq, R., 2002, Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34, 482–492.
51. Ligozzi, M., Pittaluga, F., Fontana, R., 1996, Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 40, 354–357.
52. Livermore, D.M., Brown, D.F., 2001, Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 48 Suppl 1, 59–64.
53. Livermore, D.M., Winstanley, T.G., Shannon, K.P., 2001, Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 48 Suppl 1, 87–102.
54. Long, K.S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., Vester, B., 2006, The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob Agents Chemother 50, 2500–2505.
55. MARAN-2005. Monitoring of Antimicrobial Resistance and Antibiotic Usage in The Netherlands in animals in 2005, Mevius, D., J., van Pelt, W., eds. (CIDC-Lelystad, Lelystad, The Netherlands). Meka, V.G., Gold, H.S., 2004, Antimicrobial resistance to linezolid. Clin Infect Dis 39, 1010–1015.
56. Miller, K., Dunsmore, C.J., Fishwick, C.W., Chopra, I., 2008, Linezolid and Tiamulin Cross-Resistance in Staphylococcus Aureus Mediated by Point Mutations in the Peptidyl-Transferase Center. Antimicrob Agents Chemother.
57. Paterson, D.L., Bonomo, R.A., 2005, Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18, 657–686.
58. Pfaller, M.A., Segreti, J., 2006, Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis 42 Suppl 4, S153–163.
59. Philippon, A., Arlet, G., Jacoby, G.A., 2002, Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46, 1–11.
60. Queenan, A.M., Foleno, B., Gownley, C., Wira, E., Bush, K., 2004, Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol 42, 269–275.
61. Rice, L.B., Carias, L.L., Rudin, S., Lakticova, V., Wood, A., Hutton-Thomas, R., 2005, Enterococcus faecium low-affinity pbp5 is a transferable determinant. Antimicrob Agents Chemother 49, 5007–5012.
62. Robicsek, A., Strahilevitz, J., Jacoby, G.A., Macielag, M., Abbanat, D., Park, C.H., Bush, K., Hooper, D.C., 2006, Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12, 83–88.
63. Schwarz, S., Cloeckaert, A., Roberts, M.C., 2006, Mechansims and spread of bacterial resistance to antimicrobial agents, In: Aarestrup, F.M. (Ed.) Antimicrobial resistance in bacteria of animal origin. ASM Press, Washington, pp. 73–98.
64. Schwarz, S., Kehrenberg, C., Doublet, B., Cloeckaert, A., 2004, Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev 28, 519–542.
65. Singh, K.V., Weinstock, G.M., Murray, B.E., 2002, An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 46, 1845–1850.
66. Sunde, M., Norstrom, M., 2005, The genetic background for streptomycin resistance in Escherichia coli influences the distribution of MICs. J Antimicrob Chemother 56, 87–90.
67. SVARM 2005. Swedish Veterinary Antimicrobial Resistance Monitoring. ISSN 1650-6332., Bengtsson, B., Greko, C., Grönlund-Andersson, U., eds. (National Veterinary Institute, Uppsala, Sweden).
68. Tofteland, S., Haldorsen, B., Dahl, K.H., Simonsen, G.S., Steinbakk, M., Walsh, T.R., Sundsfjord, A., 2007, Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 45, 199–205.
69. Vakulenko, S.B., Mobashery, S., 2003, Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16, 430–450.
70. Werner, G., Klare, I., Witte, W., 2002, Molecular analysis of streptogramin resistance in enterococci. Int J Med Microbiol 292, 81–94.
71. Zorzi, W., Zhou, X.Y., Dardenne, O., Lamotte, J., Raze, D., Pierre, J., Gutmann, L., Coyette, J., 1996, Structure of the low-affinity penicillin-binding protein 5 PBP5fm in wild-type and highly penicillin-resistant strains of Enterococcus faecium. J Bacteriol 178, 4948–4957.